Recombinant Anti-malaria antigen x Anti-TLR1 Bispecific Antibody (Minibody) is designed to be expressed as the anti-malaria antigen scFv fused to N-terminus of Knob-CH3 domain and the anti-TLR1 scFv to the Hole-CH3 domain, or vice versa. The CH3 domains are further stabilized by C-terminal disulfide bonds. This BsAb can retarget professional antigen-presenting cells (APCs) including DCs or NK cells to malaria antigen. It is designed for the research of Malaria therapy.
There are currently no customer reviews or questions for Recombinant Human Anti-malaria antigen x Human Anti-TLR1 Bispecific Antibody (Minibody) (MiniB-H345). Click the button below to contact us or submit your feedback about this product.
Welcome! For price inquiries, we will get back to you as soon as possible.
INQUIRYSERVICES
PRODUCTS
PLATFORMS